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Dosing of oral penicillins in children: is big child=half
an adult, small child=half a big child, baby=half a small
child still the best we can do?
The improving Children’s Antibiotic Prescribing UK Research Network thinks it’s time to
abandon this historical rule of thumb
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The penicillins have been the most important antibiotics used
in children for over 50 years. As well as combating the rapid
emergence of penicillinase producing bacteria, the development
of penicillin derivatives in the 1950s and 1960s allowed oral
dosing, removing the need for painful intramuscular injections.
Penicillin V, flucloxacillin, and amoxicillin account for nearly
4.5 million of the 6 million prescriptions for oral antibiotics
given to children in England each year.1
Despite their wide use over many decades, guidance on the
correct dose of oral penicillins for children remains confusing.
For example, the 2011 summary of product characteristics for
Amoxil paediatric suspension in children weighing <40 kg is
40-90mg/kg/day for all indications,2whereas recommendations
for amoxicillin, penicillin V, and flucloxacillin in the British
National Formulary for Children are mostly based on age bands,
although weight bands or weight based calculations (mg/kg)
are given for some indications. The widely used doses of 62.5
mg or 125 mg are fractions of the adult dose recommended in
the British National Formulary (BNF) and are still based on the
original dosing principle of a big child=half an adult, small
child=half a big child, baby=half a small child⇓⇓⇓.
Limited evidence for dosing regimens
To understand the origins of the age band dosing schedule, we
conducted a historical review of the literature and earlier UK
prescribing formularies. This comprised an electronic search of
PubMed (using a combination of terms including the antibiotic
name, child/paediatric, dose, clinical trial, review,
pharmacokinetic) and the summary of product characteristics,
a manual search through the archives of the Royal
Pharmaceutical Society of Great Britain and British Medical
Association, and requests for dosing information submitted
under the freedom of information acts to the UKMedicines and
Healthcare Products Regulatory Agency and the US Food and
Drug Administration. Electronic copies of all the articles
recovered from our search are available on request.
The first published studies on oral dosing in children were from
1946 and used penicillin G.3 4 These and subsequent studies all
used child weight to determine dosage (units/lb body weight).5-7
The results showed that the success of oral administration,
particularly in children over 1 year old, was essentially a matter
of trial and error because the variation in absorption of the drug
was so unpredictable. If 1 mg of penicillin equalled 1667 units,8
the highest dose of penicillin G that gave consistent
bacteriostatic serum levels in these studies was equivalent to
about 60 mg every 3 hours, but only in children up to 1 year
old. This meant that oral penicillin G was not practical for
children older than 1 year with severe illness, and subsequent
studies focused on attempts to prolong the therapeutic action
of a single injection of penicillin G. Two studies suggested that
doses intermediate between those used in infants and adults
should be clinically effective in children.9 10
By 1958 penicillin V had become available and was clearly the
oral antibiotic of choice. A contemporary survey published in
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theBMJ showed that manyUKgeneral practitioners had adopted
an age banding dosing system, with children aged under 5 years
old receiving 60 mg every 3 hours and older children receiving
what was then the recommended adult dose of 125 mg every 3
hours.11 Prescribing based on age, albeit using a wider range of
age bands, had first been suggested in 1953 at an antibiotic
conference held in Vienna.12 Based on the results of oral dosing
studies conducted using the scheme for penicillin G described
at the conference,13 a general recommendation to use age
banding for all antibiotics in children, irrespective of the type
of penicillin or disease indication, was published in the BMJ in
1963.14 Critically, these recommendations have remained
unchallenged and unchanged to this day.
Many children may be underdosed
Recommended dosing regimens for penicillin V (fig 1⇓) in
children first appeared in the 1963-66 edition of the BNF and
have not been changed since. The BNF recommends halving
the single dose between successive age bands starting from the
maximum adult dose of 1000 mg as follows: 12-18 years, 500
mg; 6-12 years, 250 mg; 1-5 years, 125 mg; <1 year, 62.5 mg.
The same halving of single doses between age bands from the
adult dose has also remained unchanged for flucloxacillin, which
first appeared in the 1974-76 edition of the BNF, and for
amoxicillin, which was first recommended for use in children
in the 1976-78 edition. Adult penicillin doses have increased
substantially over the years, presumably in response to concerns
around increasing antibiotic resistance, but there has been no
parallel increase in children’s dosing (fig 1⇓).
The 1963 BNF included average weight of a child with the age
band dosing information: 10 kg (birth to 1 year), 13 kg (2 years),
18 kg (5 years) and 30 kg (10 years). But data used to compile
the Health Survey for England 2009 gave the average weights
of 5 and 10 year old children as 21 kg and 37 kg, respectively,
significantly higher than the 1963 figures.15 This suggests that
the mg/kg doses may be even lower than those set in 1963.
We therefore analysed the actual dose that would be received
today as both the mg/kg/dose and mg/kg/day for the oral
penicillins based on the age bands recommended in the 2010-11
BNF for Children and the current weights of children based on
the 2009 Health Survey for England data (fig 2⇓). The main
problem with age and weight bands is that at older age-weight
ranges, substantially lower doses are always recommended.
These doses seem strikingly low—for example, a 10 year old
child weighing around 40 kg and receiving amoxicillin 250 mg
three times a day will receive only around 18 mg/kg/day, much
lower than the 40-90 mg/kg/day recommended in the summary
of product characteristics for Amoxil.
Time for an update
The evidence base for many older medicines for children is
limited, but we were surprised at the lack of recent evidence to
support the BNF’s current dosing recommendations for such
commonly used drugs as the oral penicillins. The same dosing
recommendations seem to have been reused every year for the
past 50 years (fig 1⇓). In the 1940s and early 1950s dosing was
based on weight, but age bands were introduced from the late
1950s alongside 2.5 ml and 5 ml spoons, which standardised
practice and reduced the risk of medication error. The UK’s age
band dosing recommendations are much lower than the doses
recommended by the American Academy of Pediatrics,16 for
example, but does this actually matter, or cause any harm?
Low dosing will lead to subtherapeutic concentrations at the
relevant target organ (especially the middle ear), potentially
driving antimicrobial resistance,17 18with consequences for both
the individual and the community.19 Underdosing may result in
the need for retreatment and increases the risk of severe
complications. All the published risk-benefit analyses on the
therapeutic balance of antibiotic prescribing for upper respiratory
tract infections assume adequate antibiotic dosing.20 This is a
real concern because clinically inadequate dosingwould increase
the number needed to treat to prevent any severe complications.
Studies of paediatric antiretroviral dosing noted that complex
schedules using weight bands often led to clinically important
underdosing since changes in growth and obesity had not been
accounted for.21 This work led to substantial changes in the
dosing recommendations for children receiving antiretrovirals
and to standardised treatment guidelines across Europe.22 A
similar programme of work is now required for oral penicillins.
Not only do we need to determine the effective doses for
children of all ages and weights but we also need to establish
more clearly which children really need antibiotics in the era
of pneumococcal conjugate (PCV 13),Haemophilus influenzae
B, and meningitis C vaccines. The rates of prescribing of oral
penicillins for children are now rising again in England (primary
care trust prescribing data, 2010). Many of the 5million children
in England who receive oral penicillins each year may not need
them, but those who do should receive them in an effective dose.
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Fig 1 Changes in the single oral dose of penicillin V for children and adults
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Fig 2 Actual dose of oral penicillins received as both mg/kg/dose (top) and mg/kg/day (bottom) based on age bands
recommended in the 2010-11 BNF for Children and current weights of children from 2009 Health Survey for England. (The
lowest dose of Amoxil for children under 40 kg in the summary of product characteristics)
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